|Videos|January 21, 2021
The Asenapine Transdermal System
Author(s)Leslie L. Citrome, MD, MPH
The first-and-only transdermal patch for adults with schizophrenia offers a new treatment.
Advertisement
Leslie Citrome, MD, MPH, talks about asenapine, or SECUDADO, the first-and-only transdermal patch formulation for the treatment of adults with schizophrenia approved by the U.S. Food and Drug Administration.
Read more about the asenapine transdermal system
Dr Citrome is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves Tauklarify (MK-6240) For Tau Pathology Detection in Alzheimer Disease
2
Experience With Xanomeline/Trospium in an Acute Inpatient Setting Treating Individuals With Schizophrenia
3
Phase 4 Trial of Viloxazine ER Shows Real-World Gains for ADHD With Comorbid Depression, Anxiety
4
DT120 (Lysergide) Shows Rapid, Lasting Relief for Generalized Anxiety in Phase 3 Trial
5